Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

SeaStar Medical Holding (ICUCW) Change in Accured Expenses (2023 - 2025)

SeaStar Medical Holding's Change in Accured Expenses history spans 3 years, with the latest figure at $221000.0 for Q4 2025.

  • For Q4 2025, Change in Accured Expenses fell 83.99% year-over-year to $221000.0; the TTM value through Dec 2025 reached -$920000.0, down 149.07%, while the annual FY2025 figure was -$920000.0, 149.07% down from the prior year.
  • Change in Accured Expenses reached $221000.0 in Q4 2025 per ICUCW's latest filing, up from -$1.1 million in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $1.4 million in Q4 2024 to a low of -$1.1 million in Q3 2025.
  • Average Change in Accured Expenses over 3 years is $95500.0, with a median of $44000.0 recorded in 2024.
  • The largest YoY upside for Change in Accured Expenses was 219.05% in 2025 against a maximum downside of 488.14% in 2025.
  • A 3-year view of Change in Accured Expenses shows it stood at -$350000.0 in 2023, then soared by 494.29% to $1.4 million in 2024, then tumbled by 83.99% to $221000.0 in 2025.
  • Per Business Quant, the three most recent readings for ICUCW's Change in Accured Expenses are $221000.0 (Q4 2025), -$1.1 million (Q3 2025), and -$67000.0 (Q2 2025).